Nicotine attenuates beta-amyloid-induced neurotoxicity by regulating metal homeostasis

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Jie ZhangBaolu Zhao

Abstract

Nicotine reduces beta-amyloidosis and has a beneficial effect against Alzheimer's disease (AD), but the underlying mechanism is not clear. The abnormal interactions of beta-amyloid (Abeta) with metal ions such as copper and zinc are implicated in the process of Abeta deposition in AD brains. In the present study, we investigated the effect of nicotine on metal homeostasis in the hippocampus and cortex of APP(V717I) (London mutant form of APP) transgenic mice. A significant reduction in the metal contents of copper and zinc in senile plaques and neuropil is observed after nicotine treatment. The densities of copper and zinc distributions in a subfield of the hippocampus CA1 region are also reduced after nicotine treatment. We further studied the mechanism of nicotine-mediated effect on metal homeostasis by using SH-SY5Y cells overexpressing the Swedish mutant form of human APP (APPsw). Nicotine treatment decreases the intracellular copper concentration and attenuates Abeta-mediated neurotoxicity facilitated by the addition of copper, and these effects are independent of the activation of nicotinic acetylcholine-receptor. These data suggest that the effect of nicotine on reducing beta-amyloidosis is partly mediated by regulating ...Continue Reading

References

Jul 1, 1988·Molecular and Cellular Biology·D J Thiele
Mar 1, 1988·Journal of Cellular Physiology·H J McArdle, J Tysoe
Dec 1, 1980·Journal of Neuroscience Methods·G PaxinosP C Emson
Jul 25, 1994·FEBS Letters·L HesseG Multhaup
Aug 1, 1994·Biological Trace Element Research·A MoritaY Itokawa
Oct 22, 1996·Biochemistry·A R SalomonM G Zagorski
Dec 16, 1997·Proceedings of the National Academy of Sciences of the United States of America·C Sturchler-PierratB Sommer
Jul 17, 1998·Journal of the Neurological Sciences·M A LovellW R Markesbery
Jan 19, 2000·Progress in Neurobiology·J C VickersG McCormack
Aug 26, 2000·Experimental Gerontology·T LynchA I Bush
Dec 2, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·S J HaugabookC B Eckman
Mar 7, 2001·Biological Psychiatry·M R Zamani, Y S Allen
Mar 7, 2001·Biological Psychiatry·H ZengM G Zagorski
Mar 7, 2001·Biological Psychiatry·P A NewhouseJ Corwin
Jul 27, 2001·Brain Research Bulletin·D StrausakG Multhaup
Mar 13, 2002·Nature Neuroscience·Jamuna R SubramaniamPhilip C Wong
Jun 8, 2002·Toxicology Letters·Alessio ZanardiMichele Zoli
Jun 28, 2002·Free Radical Biology & Medicine·Gerd MulthaupThomas A Bayer
Sep 7, 2002·The Journal of Biological Chemistry·Christa J MaynardQiao-Xin Li
Dec 10, 2002·Neurobiology of Aging·Ashley I Bush
Jul 2, 2003·The Journal of Biological Chemistry·Jesse Bertinato, Mary R L'Abbé
Feb 27, 2004·The Journal of Biological Chemistry·Shayne A BellinghamJames Camakaris
Sep 4, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Waldo F CerpaNibaldo C Inestrosa

❮ Previous
Next ❯

Citations

Feb 4, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Chun-Yan WangZhan-You Wang
Apr 14, 2009·Antioxidants & Redox Signaling·Zhaofei WuBaolu Zhao
Dec 12, 2012·American Journal of Respiratory and Critical Care Medicine·Nicole L NicholsGordon S Mitchell
Dec 1, 2009·Neurochemical Research·Mohammad R KhazaeiMehran Habibi-Rezaei
Jul 3, 2010·Science China. Life Sciences·JiaWei Zhou
Jan 9, 2008·Neuroscience and Biobehavioral Reviews·Concepcion Conejero-GoldbergLuis Ulloa
Aug 29, 2013·Oxidative Medicine and Cellular Longevity·Yan Zhao, Baolu Zhao
Jan 21, 2015·Pathophysiology : the Official Journal of the International Society for Pathophysiology·Omamuyovwi Meashack IjomonePolycarp Umunna Nwoha
Aug 22, 2008·Dysphagia·Emilie C SchwarzMary Behan
Dec 1, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Qiang LiuBaolu Zhao
Aug 30, 2008·The Journal of Biological Chemistry·Wei-hui WuYan-mei Li
Feb 5, 2019·Current Topics in Medicinal Chemistry·Xiaoai WuZhengxin Cai
Sep 19, 2014·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Angela Navarrete-Opazo, Gordon S Mitchell
Aug 15, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Wei ZhengZhan-You Wang
Jul 22, 2018·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Jan AasethPer M Roos
Mar 8, 2013·Chemical Biology & Drug Design·Priya NarayanSrinivasarao Raghothama

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Basal Forebrain- Circuits

Basal forebrain is a region in the brain important for production of acetylcholine and is the major cholinergic output of the CNS. Discover the latest research on circuits in the basal forebrain here.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.